← Leaderboards
Caroline Kate Vilas
University Of Texas At Austin
$109,529
Attributed
$109,529
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $37.3K · FY2019–22$50K$37.5K$25K$12.5K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$109,529 · 1
By mechanism
F31$109,529 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas At Austin
Same institution · by research overlap
- Bulent Ozpolat$4,172,713
- Elliot Max Tucker-Drob$11,296,973
- Ashley M. Henneghan$808,552
- Elizabeth Marie Cosgriff-Hernandez$4,659,193
- Michel Guillaume Nivard$1,639,654
Others in their field
Other Emerging Leaders on “Dna Polymerase Beta”
- Thomas Dick · Rbhs-New Jersey Medical School$2,706,225
- Daniel A. Pryma · University Of Pennsylvania$2,397,739
- Mark Robin Pratt · Ultima Genomics, Inc.$2,224,579
- Bradley David Gelfand · University Of Virginia$2,171,663
- Nan Su · Gentegra, Llc$2,000,000
- Daniel Joseph Mazur · Ultima Genomics, Inc.$1,999,864
Research focus
Dna Polymerase BetaDrug DesignApoptosisAdductArchitectureCancer Cell LineCancer PatientCancer TherapyCellsBaseCharacteristicsBypassChemotherapyCisplatinClonal EvolutionComplexCrosslinkCytotoxicCytotoxic AgentDeep SequencingCessation Of LifeDna AdductsDna-Directed Dna PolymeraseDrug Resistance
Grant awards (3)
A multi-scale analysis of the mutagenicity of cisplatin and its modulation of acquired chemoresistance in high-grade serous ovarian cancer$37,327
F31 · FY2022 · CA · contact PI
A multi-scale analysis of the mutagenicity of cisplatin and its modulation of acquired chemoresistance in high-grade serous ovarian cancer$36,611
F31 · FY2021 · CA · contact PI
A multi-scale analysis of the mutagenicity of cisplatin and its modulation of acquired chemoresistance in high-grade serous ovarian cancer$35,591
F31 · FY2019 · CA · contact PI